Chronic obstructive pulmonary disease: actual situation in Russia and ways to solve the problem
https://doi.org/10.18093/0869-0189-2011-0-6-69-72
Abstract
Summary. Algorithms of diagnosis and treatment of chronic obstructive pulmonary disease (COPD) and economic burden of the disease are well established in many countries but there is a lack of such information in Russia. The aim of an epidemiological survey performed in Russia was an assessment of burden of COPD, treatment strategies and patients' quality of life. The survey involved 5,376 patients with COPD. Quality of life was evaluated using the Euro Quality of Life-5Dimension questionnaire (EQ-5D). Results showed the follows: 1) most of COPD patients are able-bodied individuals; 2) COPD impacts significantly on all aspects of the patient's life; 3) treatment of COPD complies with international standards only in rare occasions; 4) patients with early stage COPD are in minority. Therefore, the survey demonstrated the urgent need in improving the knowledge of physicians and patients about COPD. This strategy could help to detect the disease in early stage, to prevent COPD progression and exacerbations.
About the Author
S. I. Ovcharenko
ГОУ ВПО "Первый Московский государственный медицинский университет им. И.М.Сеченова"
Russian Federation
Russian Federation
References
1. Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких. Федеральная программа. 2-е изд. М.; 2004.
2. Buist A.S., McBurnie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; 370: 741–750.
3. Murray C.J., Lopez A.D. Alternative projections of mortalilty and disbility by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349 (9064): 1498–1504.
4. Rabin R., de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann. Med. 2001; 33 (5): 337–343.
5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). U.S. Department of Health and Human Services, National Institute of Health, National Heart, Lung, and Blood Institute; 2006 (www.goldcopd.com).
6. Han M.R., Postma D., Mannino D.M. et al. Gender and chronic obstructive pulmonary disease: why it matters. Am. J. Respir. Crit. Care Med. 2007; 176: 1179–1184.
7. Sorheim I.C., Johannessen A., Gulsvik A. et al. Gender differencies in COPD: are women more susceptible to smoking effects than men? Thorax 2010; 65: 480–485.
8. Decramer M., Celli B., Kesten S. et al. Effect of Tiotropium on outcomes in patients with moderate COPD (UPLIFT): a prespecifies subgroup analysis of a randomised controlled trial. Lancet 2009; 374: 1171–1178.
9. Decramer M., Cooper C.B. Treatment of COPD: the sooner the better? Thorax 2010; 65: 837–841.
10. Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in COPD. Thorax 2002; 57: 847–852.
11. Spencer S., Jones P.W. Time course of ercovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003; 58: 589–593.
12. Soler-Cataluna J.J., Martinez-Garcia M.A., Roman S.P. et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925–931.
13. Rabe K.F., Hurd S., Anzueto A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176 (6): 532–555.
14. Toy E.L., Gallagher K.F., Stanley E.L. et al. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD 2010; 7: 214–228.
Review
For citations:
Ovcharenko S.I. Chronic obstructive pulmonary disease: actual situation in Russia and ways to solve the problem. PULMONOLOGIYA. 2011;(6):69-72. (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-6-69-72
Views:
1830
Email this article 